Bergantin Leandro B
Department of Pharmacology-Escola Paulista de Medicina-Universidade Federal de Sao Paulo, Rua Pedro de Toledo, 669-Vila Clementino, Sao Paulo-SP, Postal Code: 04039-032, Brazil.
Curr Hypertens Rev. 2020;16(1):73-78. doi: 10.2174/1573402115666190116095223.
Depression and hypertension are medical problems both with clearly restricted pharmacotherapies, along with a high prevalence around the world. In fact, an intensive discussion in the field is that a dysregulation of the intracellular Ca2+ homeostasis (e.g. excess of intracellular Ca2+) contributes to the pathogenesis of both hypertension and depression. Furthermore, depression rises the risk of hypertension incidence. Indeed, several data support the concept that depression is an independent risk issue for hypertension.
Then, which are the possible cellular mechanisms involved in this link between depression and hypertension? Considering our previous reports about the Ca2+ and cAMP signalling pathways (Ca2+/cAMP signalling), in this review I have discussed the virtual involvement of the Ca2+/cAMP signalling in this link (between depression and hypertension). Then, it is important to consider depression into account during the process of prevention, and treatment, of hypertension.
抑郁症和高血压都是医学问题,其药物治疗明显受限,且在全球范围内患病率很高。事实上,该领域的深入讨论表明,细胞内钙离子稳态失调(如细胞内钙离子过量)会导致高血压和抑郁症的发病机制。此外,抑郁症会增加高血压发病的风险。确实,有多项数据支持抑郁症是高血压独立风险因素这一观点。
那么,抑郁症与高血压之间这种联系可能涉及哪些细胞机制呢?考虑到我们之前关于钙离子和环磷酸腺苷信号通路(Ca2+/cAMP信号通路)的报道,在本综述中,我探讨了Ca2+/cAMP信号通路在这种联系(抑郁症与高血压之间)中的实际作用。因此,在高血压的预防和治疗过程中考虑抑郁症很重要。